4.4 Article

Effects of SlowMo, a Blended Digital Therapy Targeting Reasoning, on Paranoia Among People With Psychosis A Randomized Clinical Trial

期刊

JAMA PSYCHIATRY
卷 78, 期 7, 页码 714-725

出版社

AMER MEDICAL ASSOC
DOI: 10.1001/jamapsychiatry.2021.0326

关键词

-

资金

  1. Efficacy and Mechanism Evaluation (EME) Programme [15/48/21]
  2. Medical Research Council (MRC)
  3. National Institute for Health Research (NIHR)
  4. NIHR Biomedical Research Centre at South London and Maudsley NHS (National Health Service) Foundation Trust and King's College London
  5. NIHR [NIHR300051, NIHR-RP-2014-05-003]
  6. NIHR Oxford Health Biomedical Research Centre [BRC-1215-20005]
  7. NIHR Kent, Surrey and Sussex NIHR Applied Research Collaboration
  8. National Institutes of Health Research (NIHR) [NIHR300051] Funding Source: National Institutes of Health Research (NIHR)

向作者/读者索取更多资源

The study investigated the effects of a digitally supported reasoning intervention, SlowMo, on paranoia in patients with psychosis. While SlowMo did not show significant improvements in paranoia at 24 weeks, positive effects were indicated at an earlier point and on observer-rated paranoia and self-reported persecution at 12 and 24 weeks. Further research is needed to optimize SlowMo's effects.
IMPORTANCE Persistent paranoia is common among patients with psychosis. Cognitive-behavioral therapy for psychosis can be effective. However, challenges in engagement and effectiveness remain. OBJECTIVE To investigate the effects on paranoia and mechanisms of action of SlowMo, a digitally supported reasoning intervention, plus usual care compared with usual care only. DESIGN, SETTING, AND PARTICIPANTS This parallel-arm, assessor-blinded, randomized clinical trial recruited participants at UK community health services from May 1, 2017, to May 14, 2019. Eligible participants consisted of a referral sample with schizophrenia-spectrum psychosis and distressing, persistent (similar to 3 months) paranoia. INTERVENTIONS Individuals were randomized 1:1 to SlowMo, consisting of 8 digitally supported face-to-face sessions and a mobile app, plus usual care (n = 181) and usual care only (n = 181). MAIN OUTCOMES AND MEASURES The primary outcomewas paranoia, measured by the Green et al Paranoid Thoughts Scale (GPTS) total score at 24 weeks. Secondary outcomes included GPTS total score at 12 weeks and GPTS Part A (reference) and Part B (persecutory) scores, the Psychotic Symptom Rating Scales (PSYRATS Delusion subscale), reasoning (belief flexibility, possibility of being mistaken [Maudsley Assessment of Delusions, rated 0%-100%]), and jumping to conclusions (Beads Task). RESULTS A total of 361 participants were included in intention-to-treat analysis, of whom 252 (69.8%) were male and 249 (69.0%) were White; the mean (SD) age was 42.6 (11.6) years. At 24 weeks, 332 participants (92.0%) provided primary outcome data. Of 181 participants in the SlowMo group, 145 (80.1%) completed therapy. SlowMo plus usual care was not associated with greater reductions than usual care in GPTS total score at 24 weeks (Cohen d, 0.20; 95% CI, -0.02 to 0.40; P =.06). There were significant effects on secondary paranoia outcomes at 12 weeks, including GPTS total score (Cohen d, 0.30; 95% CI, 0.09-0.51; P =.005), Part A score (Cohen d, 0.22; 95% CI, 0.06-0.39; P =.009), and Part B score (Cohen d, 0.32; 95% CI, 0.08-0.56; P =.009), and at 24 weeks, including Part B score (Cohen d, 0.25; 95% CI, 0.01-0.49; P =.04) but not Part A score (Cohen d, 0.12; 95% CI, -0.05 to 0.28; P =.18). Improvements were observed in an observer-rated measure of persecutory delusions (PSYRATS delusion) at 12 weeks (Cohen d, 0.47; 95% CI, 0.17-0.78; P =.002) and 24 weeks (Cohen d, 0.50; 95% CI, 0.20-0.80; P =.001) and belief flexibility at 12 weeks (Cohen d, 0.29; 95% CI, 0.09-0.49; P =.004) and 24 weeks (Cohen d, 0.28; 95% CI, 0.08-0.49; P =.005). There were no significant effects on jumping to conclusions. Improved belief flexibility and worry mediated paranoia change (range mediated, 36%-56%). CONCLUSIONS AND RELEVANCE SlowMo did not demonstrate significant improvements in the primary measure of paranoia at 24 weeks; however, a beneficial effect of SlowMo on paranoia was indicated by the results on the primary measure at an earlier point and on observer-rated paranoia and self-reported persecution at 12 and 24 weeks. Further work to optimize SlowMo's effects is warranted.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据